1 U332 Institut National de la Santé et la Recherche Médicale. Institut Cochin de Génétique Moléculaire, 22 rue Méchain, 75014 Paris, France
2 Toxines Microbiennes, Institut Pasteur, 28 rue du Dr Roux 75724 Paris Cedex15, France
* Present address: Harvard Medical School, Dept of Pathology, D2-143, 200 Longwood Avenue, Boston MA-02115, USA
Author for correspondence (e-mail: conjeaud{at}cochin.inserm.fr)
Accepted October 15, 2001
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Tetraspanin, TM4SF, CD82, Rho GTPases, Cytoskeleton, T lymphocytes, Costimulation
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The cytoskeletal changes are governed by the interplay between various intracellular molecules, such as the Rho family of GTP-binding proteins, which is crucial. In fibroblasts, these proteins regulate various cytoskeletal rearrangements: RhoA controls stress fiber formation and the attachment of bundles of actin and myosin filaments to the cell membrane at points of focal adhesion, where integrin clusters are observed. Rac regulates the formation of membrane ruffles, whereas Cdc42 activation is linked to the extension of filopodia and microspikes. These GTPases are also involved in gene transcription and seem to function sequentially: Cdc42 stimulates Rac activity, which then activates Rho A (Hall, 1998). In T lymphocytes, these proteins are involved in TcR- (van Leeuwen and Samelson, 1999
), IL-2- (Arrieumerlou et al., 1998
) or CD28-mediated (Kaga et al., 1998
) activation. The activity of these GTPases is regulated by the differential binding of guanosine nucleotides. They can be switched to their active state (GTP-linked) by regulatory molecules known as guanosine exchange factors (GEFs). In hematopoietic cells, the main activators of Rho/Rac proteins during signal-transduction processes are thought to be the Vav family of proteins (Bustelo, 1996
). Their GEF activity is regulated by tyrosine phosphorylation, which also modulates their association with tyrosine kinases and adapter molecules such as SLP76. SLP76 phosphorylation is also involved in appropriate signal transduction, leading to IL-2 production, and phosphorylated SLP76 interacts with other adapter proteins and could serve as a scaffold to colocalize the GEF activity of Vav with the Rho GTPases effector proteins.
The tetraspanin family (also known as TM4SF: transmembrane-4 super family) of proteins were first identified in leukocytes, but proteins of this family are now known to be widely expressed in a variety of cells and tissues in many species. These proteins are involved in cell adhesion and motility: the expression of tetraspanins, such as CD9, CD63 and CD82, regulates the metastatic potential of some tumors (Adachi et al., 1998; Hemler et al., 1996
; Adachi et al., 1997
), and anti-tetraspanin mAbs induce homotypic aggregation and modulate cellular migration (Cao et al., 1997
; Domanico et al., 1997
; Lagaudriere-Gesbert et al., 1997a
; Shaw et al., 1995
; Yanez-Mo et al., 1998
; Maecker et al., 1997
). In addition to their role in adhesion, several studies report the ability of the anti-tetraspanin mAbs to deliver coactivation signals to leukocytes (Tai et al., 1996
; Shibagaki et al., 1998
; Levy et al., 1998
; Worthington et al., 1990
; Olweus et al., 1993
; Roberts et al., 1995
; Lebel-Binay et al., 1995a
; Lebel-Binay et al., 1995b
). No physiological ligand or counter-receptor has been reported for any of these molecules, and this suggests that tetraspanins may function as coreceptor molecules. Indeed, tetraspanins have been shown to be associated with other tetraspanins in multimeric complexes that also include ß1 integrins (Mannion et al., 1996
; Radford et al., 1996
; Rubinstein et al., 1996
; Serru et al., 1999
; Tachibana et al., 1997
) and MHC molecules (Damjanovich et al., 1998
; Lagaudriere-Gesbert et al., 1997b
; Szollosi et al., 1996
). In T lymphocytes, both CD81 and CD82 are associated with CD4 or CD8 (Imai et al., 1995
).
We previously showed that, in T lymphocytes, signaling through the tetraspanin CD82 results in stable adhesion and growth of membrane extensions and acts synergistically with TcR engagement to induce T-cell activation (Lagaudriere-Gesbert et al., 1998). Here, we have used various toxins and dominant-negative mutants to investigate whether these processes depend on the Rho family of GTPases. We found that functional GTPases were required for all the events triggered by CD82 but not for the association of the tetraspanin with the cytoskeletal matrix. However, Toxin B and other cytoskeleton-destabilizing agents diminished the CD82-induced activation of Vav and SLP76 as well as its synergistic activation of early TcR intermediates: the tyrosine kinase ZAP70 and the linker of T-cell activation (LAT). These findings indicate that an amplification loop, involving Rho-GTPases and cytoskeleton mobilization, is initiated by CD82-induced self-association with cytoskeletal components. As we observed that GFP-tagged CD82 accumulated at the site of TcR engagement, we conclude that this cytoskeleton-dependent amplification loop participates in the formation of the immunogical synapse and in the CD82 costimulatory effects.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Stimulating mAbs used were CD82 (purified C11, mouse IgG1 (Lebel-Binay et al., 1994
), purified anti-CD3 (OKT3, mouse IgG2a, the kind gift of Orthoclone), anti-CD9 (syb1, mouse IgG1, kind gift of E. Rubinstein), anti-CD81 (Z81, mouse IgG1, kind gift of F. Lanza) and control mouse IgG1 (Sigma). Anti-Cdc42 and anti-Rac mAbs were purchased from Santa Cruz Biotechnology, anti-phosphorylated tyrosine (4G10), anti-LAT (rabbit polyclonal IgG), anti-ZAP-70 (whole rabbit anti-serum), anti-Vav1 (rabbit polyclonal IgG and mouse monoclonal ascite) and anti-SLP76 (sheep polyclonal IgG) were purchased from Upstate Biotechnology and anti-c-myc mAb (9E10, mouse IgG1) from Boehringer Mannheim. Sheep HRP anti-mouse Ig and donkey HRP anti-rabbit Ig were purchased from Amersham, and goat PE anti-mouse IgG, rabbit HRP anti-sheep and goat HRP anti-mouse IgG2b were from Southern Biotechnology. C3 exoenzyme (Popoff et al., 1991
) and Toxin B (Hofmann et al., 1997
) were prepared as previously described.
The Toxin-B-treated cells were incubated for two hours at 37°C with 0.1µg/ml Toxin B (RPMI + 7% FCS). This produced total inhibition of the PMA-induced homotypic aggregation without affecting cell viability (trypan blue exclusion showed more than 95% cell viability after 10 hours in culture). C3 exoenzyme treatment was performed by electroporation (960 µF, 320 V, in electroporation buffer (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4, 2 mM EGTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione, 25 mM HEPES)) supplemented with 1 mg/ml lucifer yellow (Sigma) and 20 µg/ml C3 exoenzyme. After two hours at 37°C, live cells were collected by centrifugation (800 g) for five minutes in 10 ml FCS.
Polystyrene microbeads (Polysciences) were coated by incubating for one hour with anti-CD3 (OKT3, 20 µg/ml) at room temperature and then washed twice in PBS and saturated for 30 minutes at room temperature by incubating with PBS + 2% BSA.
Flow cytometry
For surface labeling, 3.105 cells were incubated for 30 minutes in 50 µl of saturating dilution of the different mAbs in PBS + 1% FCS. After washing thoroughly, the cells were incubated for 30 minutes with goat anti-mouse PE mAb (1/250), washed and fixed for 30 minutes in 1% PFA before being transferred to Falcon tubes in 400 µl of PBS. The same protocol was used to produce intracellular labeling of the cells, except that cells were fixed for 30 minutes in 4% PFA, washed and treated for 15 minutes in glycine buffer (Glycine 0.1 M in PBS) before being permeabilized with 0.05% saponin in PBS supplemented with 0.2% BSA and labeling with mAbs. PBS supplemented with saponin and BSA was used for all the labeling and washing steps.
Plasmids and transfections
mycN17Rac1 and pRK5mycN17Cdc42 were kindly donated by D. Cantrell and A. Hall, respectively. pEYFP-C1 and pEGFP were purchased from Clontech. YFP-CD82 was constructed by HindIII + XbaI digestion. These plasmids were transiently expressed in Jurkat-TAg cells by electroporation. Briefly, Jurkat-TAg cells were adjusted to 107 cells/ml in transfection buffer (RPMI + 20% FCS). After 15 minutes at room temperature in the presence of 15 µg of N17-Rho-GTPases or empty vector and 3 µg of GFP-encoding plasmid, 500 µl of cell suspension was subjected to an electric pulse (320V, 960 µFa) in a BioRad electroporator and re-suspended in 5 ml of culture medium. After 24 hours at 37°C, live cells were collected by Ficoll gradient, and protein expression was analyzed by flow cytometry. Maximum expression was reached two days post transfection, and almost all the GFP expressing cells (>95%) also expressed the c-myc epitope. However, N17 mutated proteins were only expressed in two thirds (N17Rac) and one third (Cdc42) of the cells, respectively. Consequently, GFP-expressing cells were sorted (ELITE, Coulter) before most of the experiments. The same protocol was used for YFP-CD82 transfection, except that GFP-encoding plasmid was not added. YFP-CD82-expressing cells were mixed with antibody-coated beads without previous sorting.
Cell stimulation
The cells were usually stimulated by being cultured on culture plates coated with anti-CD3 (OKT3) and/or anti-CD82 (C11) mAbs. The coating was performed as followed: mAbs, adjusted to the appropriate concentration in coating buffer (11 mM Na2CO3, 35 mM NaHCO3, 3 mM NaN3), were incubated overnight at 4°C on various culture supports. To avoid variations in coating efficiency on the different supports, the doses of mAbs used were well above those required for saturation. After one wash with PBS + 1% FCS, the supports were saturated for 30 minutes at 37°C with PBS + 10% FCS. For tyrosine-phosphorylation and adhesion assays, cells were plated on antibody-coated 96-well microplates in RPMI + 7% FCS at 200x103 cells per well. For the tyrosine-phosphorylation analysis of immunoprecipitates, cells were seeded at 20x106 cells in 5 ml on 10-cm Petri dishes. For the cytoskeleton rearrangement assays, cells (0.5-2x106/ml in 400 µl RPMI 7% FCS) were plated on antibody-coated Thermanox slides (Nunc), which had been pre-cleaned by serial rinses in ethanol, in the bottom of four well Multidishes on sterilized Nunclon plates (Nunc, Inc. Naperville, IL). Stimulation with anti-CD3-coated beads was performed by incubating 2x105 beads with 2x105 Jurkat cells transfected 48 hours before with YFP-CD82. After 15 minutes of contact at 37°C, the cells were plated on microscope slides, fixed with Fluoromount and analyzed on a Nikon TE300 equipped with Metaview software (Universal Imaging Corporation, Downingtown, PA).
Cytoskeleton rearrangement assays
Cells (0.5-1x106/ml in RPMI + 7% FCS) were layered over the coated Thermanox slides and incubated for various times at 37°C. Any non-adherent cells were removed by gentle washing with PBS. The remaining adherent cells were fixed with 4% paraformaldehyde, 2% sucrose in PBS for 30 minutes at room temperature. After permeabilization (one minute at 0°C with 0.1% Triton X-100, 20 mM Hepes, pH 7.4, 300 mM sucrose, 1 mM MgCl2, 1 mM CaCl2, 150 mM NaCl), F-actin was labeled by exposure to 2U/ml rhodamine-conjugated phalloidin (Molecular Probes, Eugene, OR) for 20 minutes at room temperature. Slides were mounted in Fluoromount (Southern Biotechnology) to prevent photobleaching.
Cells were analyzed by confocal fluorescence microscopy (Bio-Rad MRC1000, Bio-Rad Laboratories, Hercules, CA) equipped with a digital Diaphot 200 system. Digital pictures were analyzed using Comos software and processed using Adobe Photoshop.
Immunoprecipitation and tyrosine-phosphorylation assays
For direct tyrosine-phosphorylation assays, pretreated or untreated cells were washed twice in PBS, resuspended at 5x106 cells/ml in RPMI 1640 glutamax supplemented with 0.1% FCS, and 40 µl of this suspension was added to mAb-coated microtiter wells. The cells were incubated at 37°C and lysed at various time intervals by adding 50 µl of a 2x stock of reducing SDS-sample buffer. The samples were boiled for five minutes and the proteins separated by 10% SDS-PAGE. For immunoprecipitations of Vav, SLP76, LAT and ZAP70, proteins from 20x106 cells were solubilized in 1 ml of lysis buffer (TRIS pH 7.5, 0.5 mM NP40, 1 mM Na3VO4, 1 mM NaF, 1 mM EDTA and protease inhibitors (Bohringer tablets without EDTA) for one hour at 4°C. Protein concentrations were adjusted to 1 mg/ml and 500 µl of each sample were incubated overnight at 4°C with 4 µg of specific mAbs. Immune complexes were collected using protein G Sepharose beads (Fastflow- Sigma, two hours at 4°C) and washed five times with lysis buffer. After adding 60 µl of SDS sample and boiling for 10 minutes, 30 µl of each sample were separated by 7.5% (forVav, SLP76 and ZAP70) or 12% (for LAT) SDS-PAGE. To detect tyrosine phosphorylation, the proteins were electrophoretically transferred onto a polyvylidene difluoride membrane (Dupont-New England Nuclear). Anti-phosphotyrosine immunoblotting was performed using mAb 4G10 (UBI) followed by horseradish-peroxidase-conjugated goat anti-mouse immunoglobulin G2b (GaM-IgG2b, Southern Biotechnology). Immunoreactive proteins were visualized using the ECL Western Blotting Detection Kit (Amersham).
Separation of soluble and insoluble fractions
Cells were washed twice in PBS, re-suspended at 106 cells/ml in complete medium, and 2 ml of this suspension were added to plastic dishes coated or not with mAbs. The cells were incubated for various times at 37°C cells, solubilized with 0.5% NP-40 in a Tris-buffered saline solution (TBS: 150 mM NaCl, 10 mM Tris (pH 7.3)), containing protease inhibitors (Boehringer cocktail inhibitors tablets) for one hour on ice and centrifuged at 10,000 g for 15 minutes at 4°C to pellet the insoluble material. Prior to separation on SDS-PAGE, the insoluble pellet was resolubilized by boiling in non-reducing SDS-sample buffer. Proteins were fractionated by 12% SDS-PAGE and transferred onto polyvylidene difluoride membranes (Dupont-New England Nuclear). CD82 was detected using C11 mAb followed by horseradish-peroxidase-conjugated SaM immunoglobulin (Amersham) and an ECL Western Blotting Detection Kit (Amersham). Kodak films were analyzed and quantified by visible illumination on Bioprofil gel analyzer
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Among the various proteins that were phosphorylated by optimal anti-CD3 stimulation (Fig. 1A, lane 2 aCD3o), two main proteins with bands at 90-100 and 75-80 kDa were also induced by CD82 engagement (Fig. 1A, lane 3, aCD82). These bands comigrated with Vav1 and SLP76 respectively (Fig. 1A, middle and lower panels). To formally identify these two molecules, which are known to be involved in the Rho GTPase activation pathway, immunoprecipitation experiments with specific mAbs were performed. As shown in Fig. 1B (upper panel), immunoprecipitation of Jurkat cell lysates with Vav-1-specific antibodies showed that the phosphorylation of Vav-1 was markedly increased by CD82 triggering (Fig. 1B, compare lane 1 and 2, upper band). Interestingly, CD82 triggering led Vav-1 to coprecipitate a 75 kDa tyrosine-phosphorylated protein, which suggests that activated Vav-1 may be associated with SLP76. The CD82-induced association of Vav-1 with SLP76 was confirmed by immunoblotting Vav-1 immunoprecipitates with anti-SLP76-specific antibodies (Fig. 1B, lower panel) and by reciprocal experiments. Two bands, migrating at 95-100 and 75-80 kDa respectively, were precipitated by anti-SLP76 antibodies (Fig. 1B, upper panel, lane 6 compared to lane 5) and were identified by immunoblotting as Vav-1 and SLP76 (Fig. 1B, middle and lower panels).
|
Morphological changes induced by CD82 are dynamically dependent upon functional Rho GTPases
The observation that CD82 engagement triggers the tyrosine phosphorylation of Vav1, a specific guanine exchange factor of the Rho family GTPases, and its association with the adaptor protein SLP76, led us to investigate whether the CD82-signaling pathway involves the Rho GTPases. We treated Jurkat cells with C. difficile Toxin B, an enzyme that uses UDP-glucose as a substrate to inactivate Rho, Rac and Cdc42 (Just et al., 1995). Preliminary experiments revealed that 0.1 µg/ml of Toxin B was sufficient to inhibit the phorbol-ester-induced homotypic aggregation of Jurkat cells without affecting their viability for up to 24 hours. After two hours of pretreatment with, or without, Toxin B, Jurkat cells were cultured on anti-CD82-coated plates for one hour, and cytoskeletal alterations were visualized by actin staining.
Fifteen minutes of culture on anti-CD82coated plates was enough to induce the adhesion and spreading of the untreated Jurkat cells and to increase the area in contact with the culture plate. After one hour, the untreated cells developed typical membrane extensions, such as pseudopodia, lamellipodia and filopodia, in which dense actin structures were observed (Fig. 2a,c). Toxin B pretreatment drastically inhibited the CD82-induced cell adhesion. Furthermore, the remaining adherent cells did not spread but retained their spherical shape (Fig. 2b). After culture on control antibodies, anti-CD3 (OKT3) or anti-MHC-I (W6.32), adhesion could be observed albeit weakly and transiently, and the cells never developed the CD82-induced typical membrane extensions (data not shown) (Lagaudriere-Gesbert et al., 1998). In contrast, culturing Jurkat cells on other anti-tetraspanin antibodies led to reduced but typical morphological changes (Lagaudriere-Gesbert et al., 1997a
).
|
These findings indicate that the CD82-induced morphological changes are dynamic processes that require functional Rho GTPases for their initiation and maintenance.
Active Rho A, Cdc42 and Rac are involved in the CD82-induced morphological changes
We next examined the specific role of each of the GTPases in the morphological changes triggered by CD82 engagement. First we used C3 exoenzyme from C. botulinum, which selectively ADP-ribosylates Rho (Aktories, 1994), inhibiting its membrane translocation and effector recognition. In the absence of a functional receptor for the toxin, exoenzyme C3 was electroporated into the cells together with an exclusion dye, Lucifer Yellow, which made it possible to identify the permeabilized cells. Two hours post electroporation, live cells were stimulated by culture on anti-CD82-coated plates before morphological analysis. As shown on Fig. 3a, Lucifer-Yellow-electroporated Jurkat cells spread and developed membrane extensions, whereas exoenzyme-C3-treated cells (Fig. 3b) exhibited a round shape similar to that observed following exposure to Toxin B.
|
Expression of N17Rac or N17Cdc42 did not alter the morphology of unstimulated Jurkat cells (not shown). In contrast with cells transfected with GFP and empty vector, which displayed the usual morphologic changes in response to CD82 engagement (Fig. 4a), many cells expressing N17Rac (Fig. 4b) or N17Cdc42 (Fig. 4c) were not adherent. A large fraction of the remaining adherent cells did not develop any morphological change, but presented phenotypes similar to those observed in response to Toxin B or exoenzyme C3 treatment. However, a small fraction of the adherent cells did develop specific morphological changes. Some N17Rac1-expressing cells developed numerous filopodia (Fig. 4d), but lamellipodia were never observed. Those expressing N17Cdc42 showed the opposite phenotypic outcome, some of the cells were widely spread and displayed very large protrusions such as lamellipodia (Fig. 4c,e) but never developed filopodia.
|
Specific and Rho GTPase independent association of CD82 with the cytoskeleton
We had previously observed that a fraction of CD82 is associated with the insoluble cell pellet in response to CD82 engagement (Lagaudriere-Gesbert et al., 1998). Since tetraspanins CD9, CD81 and CD82 were shown to associate with each others and to share biochemical properties as well as signaling functions (Lagaudriere-Gesbert et al., 1998
), we compared the abilities of CD9, CD81 and CD82 to induce their own association or that of other tetraspanins with insoluble fractions. Jurkat T cells, cultured for 15 minutes on anti-tetraspanin mAbs, were solubilized for one hour on ice with 0.5% NP-40. After fractionation of the soluble and insoluble material, SDS-PAGE and immunoblotting using anti-tetraspanin mAbs were performed. As shown in Fig. 5A (upper panel) only CD82 could be recovered in the insoluble fractions whatever stimulation was used. A very large amount of CD82 was translocated from the soluble to the insoluble fractions upon CD82 engagement (Fig. 5A, upper panel, soluble and insoluble fractions, lanes 2); however a small amount of CD82 was also recovered from the insoluble pellet upon engagement of CD81 (insoluble fractions, upper panel, lane 4) and sometimes after CD9 triggering. In contrast, whatever the tetraspanin engaged, CD81 (Fig. 5A, lower panel) and CD9 (not shown) were never recovered from the insoluble pellet (middle and lower lanes).
|
Since, CD82 translocation with the insoluble fraction was strictly dependent on actin polymerization (Lagaudrière-Gesbert et al., 1998) and independent of cholesterol depletion or solubilization (unpublished results), we concluded that among the tetraspanins known to form large multimeric complexes, CD82 has a specific ability to associate with the cytoskeleton. Furthermore, its independence of the activity of the Rho GTPases, suggests that the CD82-cytoskeleton association is one of the primary events of the CD82 signaling cascade.
Cytoskeleton mobilization is part of an amplification loop that enhances CD82-induced Vav and SLP76 phosphorylation
As the CD82 signaling cascade requires an intact cytoskeleton, we also investigated the functional interplay between CD82 and the cytoskeleton by studying the effects of various cytoskeleton inhibitors on the primary tyrosine-phosphorylation events triggered by CD82. Tyrosine phosphorylations induced by culture on anti-CD82-coated microplates were compared on Toxin B or cytochalasin pretreated Jurkat cells (a strong inhibitor of actin polymerization). As shown in Fig. 6, CD82-induced phosphorylation of both Vav and SLP76 were reduced by pretreatment with cytochalasin or, to a lesser extent, with Toxin B.
|
Rho-GTPase activation is required for CD82 costimulatory activity
We have previously shown that CD82 cooperates with TcR-CD3 complexes to achieve full T-cell activation. To determine whether this interplay also involves Rho GTPases, we used Toxin B pretreatment or expression of dominant-negative N17Cdc42 or N17Rac1 (as described above in) to investigate the impact of Rho GTPase inactivation on primary tyrosine phosphorylations. Control experiments revealed that Toxin B did not modify the IL-2 mRNA induced by optimal stimulation (20 µg of aCD3 + PMA) but totally inhibited the costimulatory activity of CD82 (not shown). This indicated that Toxin B was not toxic at the doses used in these experiments and suggested that cosignaling via CD82 required Rho GTPase activation.
Engagement of CD82 alone induced mainly the tyrosine phosphorylation of two proteins with molecular weights of 95-100 and 75-80 kDa (Vav1 and SLP76, respectively) (Fig. 1A; Fig. 6). In contrast, coengagement of CD82 (Fig. 7A, left panel, CD82+CD3s) combined with a weak TcR signaling (Fig. 7A, left panel, CD3s) to induce strong tyrosine phosphorylation of other proteins, particularly at 70 and 35 kDa, which was not detected with CD82 engagement alone. Similar proteins were tyrosine phosphorylated in response to costimulation (Fig. 7A, left panel, CD82+CD3s) and optimal TcR stimulation (Fig. 7A, left panel, CD3o). The potentiating effect of CD82 on TcR signaling was strongly inhibited when Rho GTPases were inhibited by Toxin B (Fig. 7A, lane 7 compared to lane 6). Using western blotting, two of these proteins could be identified as ZAP70 (70 kDa, Fig. 7B) and LAT (35 kDa) (data not shown). Since these two proteins are essential molecules involved in signaling pathways downstream of the T-cell receptor and are necessary to trigger IL-2 production in T cells (Zhang et al., 1998), immuno-precipitation with specific anti-LAT and anti-ZAP70 antibodies was performed. As expected, a marked reduction in the CD82-induced tyrosine phosphorylation of both ZAP70 and LAT was observed after treatment with Toxin B (Fig. 7C). Inactivation of Rac or Cdc42 also reduced the synergistic effect of CD82 on the tyrosine phosphorylation of various proteins (Fig. 7A, right panel) but did not modify the pattern of tyrosine-phosphorylated proteins in unstimulated cells (not shown). More marked inhibition was observed after the expression of N17Rac1, which may indicate that this GTPase plays a major role in the CD82 costimulatory pathway. However, we cannot rule out the possibility that these effects resulted from lower expression of N17Cdc42 than of N17Rac1. As shown in Fig. 7A (lanes 4-5), Toxin B also partly inhibited the tyrosine phosphorylations induced by optimal CD3/TcR stimulation.
|
CD82 accumulates at the site of TcR engagement
To address the physiological relevance of the effects induced by aggregation of the molecules using immobilized antibodies more directly, we tried to find out whether engagement of the CD3-TcR complexes modifies the surface distribution of CD82. Anti-CD3 coated microspheres are commonly used as a model for the study of the cellular interactions involved in T-cell activation. Using this system, we analyzed the redistribution of GFP-tagged CD82, overexpressed at the Jurkat cell surface by transient expression. Unstimulated YFP-CD82 expressing cells displayed uniform surface staining (Fig. 8A), whereas YFP-transfected cells exhibited intracellular staining (not shown). As shown in Fig. 8, similar uniform surface staining was observed on the few cells that were in contact with beads coated with an irrelevant antibody (Fig. 8B). In contrast, after 15 minutes of contact with anti-CD3 coated beads, YFP-CD82 molecules were clearly redistributed at contact sites with anti-CD3 coated beads (Fig. 8C).
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We selectively inhibited Rho, Rac or Cdc42 in Jurkat cells to study the functional role of each protein separately. Inactivation of Rho A, using exoenzyme C3, Rac1 or Cdc42, by expression of their respective dominant-negative forms, inhibited most of the CD82-induced adhesion and morphological changes. However, when the negative dominant of Rac1 or Cdc42 was expressed, some CD82-stimulated cells exhibited particular phenotypes. Fine extensions similar to filopodia were observed in response to N17Rac, whereas some N17Cdc42-expressing cells developed lamellipodia and membrane ruffling but no filopodia. These findings are in agreement with observations in other cell types: Rac1 activation leads mainly to the development of membrane ruffling, whereas Cdc42 is known to be involved in the extension of microspikes and filopodia. The classical cascade (Cdc42 stimulating Rac that in turn activates RhoA) (Nobes and Hall, 1995) could not account for the different phenotypes observed in our experiments. However, the complete inhibition of the morphological changes that was observed when only RhoA was inactivated may result from dynamic processes (Burridge, 1999
). The regulatory activity of RhoA could be important in the contractile events required for maintaining stationary cell spreading, and Rac and Cdc42 could be involved in the regulation of early stages of cell spreading (Sanders et al., 1999
). In contrast with the experiments described by Moorman and colleagues (Moorman et al., 1999
) in which they demonstrated that viral expression of exoenzyme C3 in the leukemic cell line EL4 led to the appearance of transient membrane ruffles and development of microspikes, our results concerned the long-term induction of adhesion and development of membrane extensions by CD82, where Rho A activity may also be required. Alternatively, it is possible that exoenzyme C3 could modify other Rho GTPases (such as Rnd3 and RhoE), which could be involved upstream in the CD82-signaling pathway.
CD82 has an internalization consensus sequence in its the C-terminus. The presence of CD82 in internalization vesicles (unpublished observations) (Escola et al., 1998; Hammond et al., 1998
; Kannan et al., 1995
), indicates that this site may be functional. In a previous study, we described that, upon engagement, part of CD82 translocates to the detergent insoluble fraction in an F-actin-dependent manner. In the present study, we demonstrate that CD82 is the only tetraspanin highly expressed on T cells that displays this property independently of Rho-GTPase activation. The association of CD82 with insoluble membrane fractions, which peaks within five minutes of activation, was also observed in response to the engagement of other tetraspanins.
Overall, our results suggest that, upon engagement, CD82 associates with the cytoskeleton, which promotes tyrosine phosphorylation and the association of both the guanine exchange factor Vav and adapter protein SLP76. These early events lead to de novo actin polymerization, which depends on Rho GTPase activation. The observation both that Rho GTPase inactivation and cytoskeletal destabilization decreased Vav and SLP76 tyrosine phosphorylation suggests that actin polymerization facilitates CD82-induced Vav and SLP76-phosphorylation. Association between membrane molecules and the cytoskeleton (Pardi et al., 1992; Rozdzial et al., 1995
) have been reported to play a crucial role in cell activation. And the signaling cascade that leads to cytoskeleton mobilization has to be intact for T cell activation (Delon et al., 1998
; Lowin-Kropf et al., 1998
; Penninger and Crabtree, 1999
; Valitutti et al., 1995
). Recent data demonstrate that TcR-mediated stimulation leads to a cytoskeleton-dependent reorganization of various membrane proteins, including adhesion molecules, in the contact area of T cells and APC (Monks et al., 1998
). On the basis of the reciprocal synergy between TcR and CD82 signaling pathways (Lagaudriere-Gesbert et al., 1998
) and the correlation between the intensity of the morphological changes induced by various tetraspanins and their co-stimulating abilities (Lagaudriere-Gesbert et al., 1997a
), we have already suggested that cytokeletal mobilization may be the main effector in the tetraspanin-mediated adhesion and activation process. The present data reinforce this hypothesis and suggest that CD82 plays a specific role as a result of its ability to associate with the cytoskeleton. TcR signaling involves src-kinase activation, TcR/CD3
chain tyrosine phosphorylation and association with the cytoskeleton as well as the recruitment and phosphorylation of the tyrosine kinase ZAP70. Activation of ZAP70 induces the tyrosine phosphorylation of the integral membrane adapter LAT, and this in turn recruits crucial signaling molecules to the membrane. We demonstrate here that the costimulatory effects induced by CD82 on these early TcR signaling events (tyrosine phosphorylation of the early TcR intermediates ZAP70 and LAT) were strongly reduced by Toxin B and, to a lesser extent, by the expression of the dominant-negative form of Rac or Cdc42. Furthermore, this partial inhibition of early activation stages was correlated with total inhibition of the induction of IL-2 mRNA. We found that Toxin B (or the expression of N17Rac or N17Cdc42) had marginal effects on the tyrosine phosphorylations induced by the engagement of a large number of TcR-CD3 complexes. Similarly, Toxin-B-treated cells normally produced IL-2 in response to the crosslinking of a large and saturating number of TcR-CD3 complexes in the presence of phorbol esters. These negative results are probably linked to the extreme stimulation conditions used (extensive TcR crosslinking), which avoided the absolute requirement for a functional cytoskeleton.
Various effectors, including receptor tyrosine kinases, Syk/ZAP70 and the Jak family of tyrosine kinases, have been reported to phosphorylate Vav. We failed to detect any significant increase in ZAP70 or LAT tyrosine phosphorylation following CD82 engagement. We are currently investigating whether the tyrosine kinase p56lck, which is constitutively activated in Jurkat cells, is recruited upon CD82 engagement. Indeed, in T lymphocytes, p56lck is known to associate with CD4, which is reported to associate with CD82. However, this association is thought to occur only when CD4 has uncoupled p56lck (Imai et al., 1995). Integrins, which are also reported to associate with tetraspanins, could also link tetraspanin signaling to Vav phosphorylation (Moores et al., 2000
; Zheng et al., 1996
). Indeed, integrin and tetraspanin functions seem intimately linked. Recently, Yauch and coworkers (Yauch and Hemler, 2000
) have shown that some tetraspanins (CD9, CD81, CD151 and A15/TALLA1), but not CD82, associate at the cell membrane with a PtdIns4P 5-kinase and are necessary for integrin-mediated lipid-kinase activity. Recent studies have demonstrated that tetraspanins colocalize with and amplify the signaling functions of integrins in various adhesion processes involved in cell development (Berditchevski and Odintsova, 1999
; Shaw et al., 1995
; Tachibana and Hemler, 1999
). However, CD82, which presents one of the weaker associations with integrins among the tetraspanins highly expressed on activated T cells (Serru et al., 1999
), was shown to be the more potent at delivering cytoskeletal and coactivation signals to T cells (Lagaudriere-Gesbert et al., 1997a
).
To our knowledge, no counter receptor or physiological ligand for tetraspanins has yet been identified. As previously discussed, physiological tetraspanin triggering could occur through their various associated receptors (e.g. integrins, CD4 and MHC). The functional effects observed upon tetraspanin engagement could also reflect their key role in the membrane dynamics as membrane facilitators (Maecker et al., 1997) or membrane organizers (Lagaudriere-Gesbert et al., 1998
), as suggested by the rapid redistribution of CD82 observed after engagement of the T-cell receptor. Recently, the tetraspanin-like proteins Rom and RDS expressed in the disk rims of photoreceptor outer segments have been shown to regulate disk morphogenesis (Clarke et al., 2000
), and uroplakins have been shown to be directly involved in the quasi-crystalline structure of the bladder membrane (Liang et al., 2001
). Through their ability to associate with each other and to link various surface molecules together to form a tetraspanin network (the tetraspanin web), and, in some cases, to bind with and to mobilize the cytoskeleton through Vav and Rho-GTPase activation, these molecules could play an essential role in membrane structure and dynamics. Such properties could explain why these molecules are directly involved in fundamental processes such as cell activation, adhesion, morphogenesis, growth and metastasis.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Adachi, M., Taki, T., Ieki, Y., Ko, S., Higashiyama, S., Kodama, K., Doi, S. and Miyake, M. (1997). KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis. Nippon Kyobu Geka Gakkai Zasshi 45, 398-401.[Medline]
Adachi, M., Taki, T., Konishi, T., Huang, C. I., Higashiyama, M. and Miyake, M. (1998). Novel staging protocol for non-small-cell lung cancers according to MRP- 1/CD9 and KAI1/CD82 gene expression. J. Clin. Oncol. 16, 1397-1406.[Abstract]
Aktories, K. (1994). Clostridial ADP-ribosylating toxins: effects on ATP and GTP-binding proteins. Mol. Cell. Biochem. 138, 167-176.[Medline]
Arrieumerlou, C., Donnadieu, E., Brennan, P., Keryer, G., Bismuth, G., Cantrell, D. and Trautmann, A. (1998). Involvement of phosphoinositide 3-kinase and Rac in membrane ruffling induced by IL-2 in T cells. Eur. J. Immunol. 28, 1877-1885.[Medline]
Berditchevski, F. and Odintsova, E. (1999). Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J. Cell Biol. 146, 477-492.
Burridge, K. (1999). Crosstalk between Rac and Rho. Science 283, 2028-2029.
Bustelo, X. R. (1996). The VAV family of signal transduction molecules. Crit. Rev. Oncog. 7, 65-88.[Medline]
Cao, L., Yoshino, T., Kawasaki, N., Sakuma, I., Takahashi, K. and Akagi, T. (1997). Anti-CD53 monoclonal antibody induced LFA-1/ICAM-1-dependent and independent lymphocyte homotypic cell aggregation. Immunobiology 197, 70-81.[Medline]
Clarke, G., Goldberg, A. F., Vidgen, D., Collins, L., Ploder, L., Schwarz, L., Molday, L. L., Rossant, J., Szel, A., Molday, R. S. et al. (2000). Rom-1 is required for rod photoreceptor viability and the regulation of disk morphogenesis. Nat. Genet. 25, 67-73.[Medline]
Damjanovich, S., Matko, J., Matyus, L., Szabo, G., Jr., Szollosi, J., Pieri, J. C., Farkas, T. and Gaspar, R., Jr. (1998). Supramolecular receptor structures in the plasma membrane of lymphocytes revealed by flow cytometric energy transfer, scanning force- and transmission electron-microscopic analyses. Cytometry 33, 225-233.[Medline]
Delon, J., Bercovici, N., Liblau, R. and Trautmann, A. (1998). Imaging antigen recognition by naive CD4+ T cells: compulsory cytoskeletal alterations for the triggering of an intracellular calcium response. Eur. J. Immunol. 28, 716-729.[Medline]
Domanico, S. Z., Pelletier, A. J., Havran, W. L. and Quaranta, V. (1997). Integrin alpha 6A beta 1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate. Mol. Biol. Cell 8, 2253-2265.
Escola, J. M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O. and Geuze, H. J. (1998). Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B- lymphocytes. J. Biol. Chem. 273, 20121-20137.
Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
Hammond, C., Denzin, L. K., Pan, M., Griffith, J. M., Geuze, H. J. and Cresswell, P. (1998). The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM and -DO molecules. J. Immunol. 161, 3282-3291.
Hemler, M. E., Mannion, B. A. and Berditchevski, F. (1996). Association of TM4SF proteins with integrins: relevance to cancer. Biochim. Biophys. Acta 1287, 67-71.[Medline]
Hofmann, F., Busch, C., Prepens, U., Just, I. and Aktories, K. (1997). Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272, 11074-11078.
Imai, T., Kakizaki, M., Nishimura, M. and Yoshie, O. (1995). Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J. Immunol. 155, 1229-1239.[Abstract]
Just, I., Selzer, J., Wilm, M., von Eichel-Streiber, C., Mann, M. and Aktories, K. (1995). Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, 500-503.[Medline]
Kaga, S., Ragg, S., Rogers, K. A. and Ochi, A. (1998). Stimulation of CD28 with B7-2 promotes focal adhesion-like cell contacts where Rho family small G proteins accumulate in T cells. J. Immunol. 160, 24-27.
Kannan, K., Divers, S. G., Lurie, A. A., Chervenak, R., Fukuda, M. and Holcombe, R. F. (1995). Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy. Eur. J. Haematol. 55, 145-151.[Medline]
Lagaudriere-Gesbert, C., Le Naour, F., Lebel-Binay, S., Billard, M., Lemichez, E., Boquet, P., Boucheix, C., Conjeaud, H. and Rubinstein, E. (1997a). Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol. 182, 105-112.[Medline]
Lagaudriere-Gesbert, C., Lebel-Binay, S., Wiertz, E., Ploegh, H. L., Fradelizi, D. and Conjeaud, H. (1997b). The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes. J. Immunol. 158, 2790-2797.[Abstract]
Lagaudriere-Gesbert, C., Lebel-Binay, S., Hubeau, C., Fradelizi, D. and Conjeaud, H. (1998). Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation. Eur. J. Immunol. 28, 4332-4344.[Medline]
Lebel-Binay, S., Gil, M. L., Lagaudriere, C., Miloux, B., Marchiol-Fournigault, C., Quillet-Mary, A., Lopez, M., Fradelizi, D. and Conjeaud, H. (1994). Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells. Cell. Immunol. 154, 468-483.[Medline]
Lebel-Binay, S., Lagaudriere, C., Fradelizi, D. and Conjeaud, H. (1995a). CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol. 155, 101-110.[Abstract]
Lebel-Binay, S., Lagaudriere, C., Fradelizi, D. and Conjeaud, H. (1995b). CD82, tetra-span-transmembrane protein, is a regulated transducing molecule on U937 monocytic cell line. J. Leukoc. Biol. 57, 956-963.[Abstract]
Levy, S., Todd, S. C. and Maecker, H. T. (1998). CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16, 89-109.[Medline]
Liang, F. X., Riedel, I., Deng, F. M., Zhou, G., Xu, C., Wu, X. R., Kong, X. P., Moll, R. and Sun, T. T. (2001). Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem. J. 355, 13-18.[Medline]
Lowin-Kropf, B., Shapiro, V. S. and Weiss, A. (1998). Cytoskeletal polarization of T cells is regulated by an immunoreceptor tyrosine-based activation motif-dependent mechanism. J. Cell Biol. 140, 861-871.
Maecker, H. T., Todd, S. C. and Levy, S. (1997). The tetraspanin superfamily: molecular facilitators. Faseb J. 11, 428-442.
Mannion, B. A., Berditchevski, F., Kraeft, S. K., Chen, L. B. and Hemler, M. E. (1996). Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J. Immunol. 157, 2039-2047.[Abstract]
Monks, C. R., Freiberg, B. A., Kupfer, H., Sciaky, N. and Kupfer, A. (1998). Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86.[Medline]
Moores, S. L., Selfors, L. M., Fredericks, J., Breit, T., Fujikawa, K., Alt, F. W., Brugge, J. S. and Swat, W. (2000). Vav family proteins couple to diverse cell surface receptors. Mol. Cell. Biol. 20, 6364-6373.
Moorman, J. P., Luu, D., Wickham, J., Bobak, D. A. and Hahn, C. S. (1999). A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival. Oncogene 18, 47-57.[Medline]
Nobes, C. D. and Hall, A. (1995). Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem. Soc. Trans. 23, 456-459.[Medline]
Olweus, J., Lund-Johansen, F. and Horejsi, V. (1993). CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells. J. Immunol. 151, 707-716.
Pardi, R., Inverardi, L., Rugarli, C. and Bender, J. R. (1992). Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes. J. Cell Biol. 116, 1211-1220.[Abstract]
Penninger, J. M. and Crabtree, G. R. (1999). The actin cytoskeleton and lymphocyte activation. Cell 96, 9-12.[Medline]
Popoff, M. R., Hauser, D., Boquet, P., Eklund, M. W. and Gill, D. M. (1991). Characterization of the C3 gene of Clostridium botulinum types C and D and its expression in Escherichia coli. Infect Immun 59, 3673-3679.[Medline]
Radford, K. J., Thorne, R. F. and Hersey, P. (1996). CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem. Biophys. Res. Commun. 222, 13-18.[Medline]
Roberts, J. J., Rodgers, S. E., Drury, J., Ashman, L. K. and Lloyd, J. V. (1995). Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen. Br. J. Haematol. 89, 853-860.[Medline]
Rozdzial, M. M., Malissen, B. and Finkel, T. H. (1995). Tyrosine-phosphorylated T cell receptor zeta chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. Immunity 3, 623-633.[Medline]
Rubinstein, E., Le Naour, F., Lagaudriere-Gesbert, C., Billard, M., Conjeaud, H. and Boucheix, C. (1996). CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26, 2657-2665.[Medline]
Sanders, L. C., Matsumura, F., Bokoch, G. M. and de Lanerolle, P. (1999). Inhibition of myosin light chain kinase by p21-activated kinase. Science 283, 2083-2085.
Serru, V., Le Naour, F., Billard, M., Azorsa, D. O., Lanza, F., Boucheix, C. and Rubinstein, E. (1999). Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem. J. 340, 103-111.[Medline]
Shaw, A. R., Domanska, A., Mak, A., Gilchrist, A., Dobler, K., Visser, L., Poppema, S., Fliegel, L., Letarte, M. and Willett, B. J. (1995). Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 270, 24092-24099.
Shibagaki, N., Hanada, K., Yamaguchi, S., Yamashita, H., Shimada, S. and Hamada, H. (1998). Functional analysis of CD82 in the early phase of T cell activation: roles in cell adhesion and signal transduction. Eur. J. Immunol. 28, 1125-1133.[Medline]
Szollosi, J., Horejsi, V., Bene, L., Angelisova, P. and Damjanovich, S. (1996). Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157, 2939-2946.[Abstract]
Tachibana, I., Bodorova, J., Berditchevski, F., Zutter, M. M. and Hemler, M. E. (1997). NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J. Biol. Chem. 272, 29181-29189.
Tachibana, I. and Hemler, M. E. (1999). Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J. Cell. Biol. 146, 893-904.
Tai, X. G., Yashiro, Y., Abe, R., Toyooka, K., Wood, C. R., Morris, J., Long, A., Ono, S., Kobayashi, M., Hamaoka, T. et al. (1996). A role for CD9 molecules in T cell activation. J. Exp. Med. 184, 753-758.[Abstract]
Valitutti, S., Dessing, M., Aktories, K., Gallati, H. and Lanzavecchia, A. (1995). Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181, 577-584.[Abstract]
van Leeuwen, J. E. and Samelson, L. E. (1999). T cell antigen-receptor signal transduction. Curr. Opin. Immunol. 11, 242-248.[Medline]
Worthington, R. E., Carroll, R. C. and Boucheix, C. (1990). Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br. J. Haematol. 74, 216-222.[Medline]
Wulfing, C. and Davis, M. M. (1998). A Receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 282, 2266-2269.
Yanez-Mo, M., Alfranca, A., Cabanas, C., Marazuela, M., Tejedor, R., Ursa, M. A., Ashman, L. K., de Landazuri, M. O. and Sanchez-Madrid, F. (1998). Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J. Cell Biol. 141, 791-804.
Yauch, R. L. and Hemler, M. E. (2000). Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem. J. 351, 629-637.[Medline]
Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P. and Samelson, L. E. (1998). LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92, 83-92.[Medline]
Zheng, L., Sjolander, A., Eckerdal, J. and Andersson, T. (1996). Antibody-induced engagement of beta 2 integrins on adherent human neutrophils triggers activation of p21ras through tyrosine phosphorylation of the protooncogene product Vav. Proc. Natl. Acad. Sci. USA 93, 8431-8436.